CClinicalTrials.gg
CompletedNCT01365364DOPATRANSPLMUpdated Jun 3, 2011

Dopamine Transporter Density Profiles in Patients With Periodic Limb Movements

An interventional study of Aerobic Physical Exercise and Aerobic Physical Exercise in Periodic Limb Movements in Sleep, sponsored by Federal University of São Paulo. Completed at 1 site in Brazil. Open to male participants aged 45 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2011-06-03.

Sponsored by Federal University of São Paulo · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
16
Allocation
Randomized
Ages
45 Years to 65 Years
Sex
Male
01

Study summary

Restless legs syndrome and periodic limb movement (PLM)are sleep-related movement disorders and studies have shown changes in striatal dopaminergic activity in patients with these disorders. Physical exercise has been shown to improve the symptoms of restless legs syndrome and PLM, as has treatment with dopamine agonists. However, the mechanism by which physical exercise acts as a non-pharmacological treatment in improving symptoms of restless legs syndrome and PLM remains unknown. The investigators evaluated dopamine transporter density profiles in 16 sedentary patients (control and experimental - with PLM, groups) and the influence of acute physical exercise on its concentration after a maximal exercise test. Each patient underwent baseline polysomnography to evaluate sleep patterns and PLM index values. After obtaining the polysomnography baseline, the single photon emission computer tomography baseline was determined. Subsequently, the volunteers performed a maximal exercise test in the morning, followed by a single photon emission computer tomography two hours later and polysomnography that night, to assess the effect of acute physical exercise on dopamine transporter and sleep patterns. The results showed significant lower dopamine transporter baseline densities in the striatum region for the experimental group. The results also showed a significant reduction in the periodic leg movement rate in the experimental group and a significant increased percentage of stage-1 non-REM sleep in both groups after maximal exercise test. Significant differences between the groups were only observed for Stage 2 sleep and slow wave sleep. Our results show that patients with PLM had a lower dopamine transporter density in the left putamen region compared to the control group and an acute physical exercise (maximal exercise test) did not alter this profile, providing evidence that this improvement is the result of chronic physical exercise.

Read the detailed description

Experimental Design Each volunteer (in both control and experimental groups) underwent Polysomnography (PSG) adaptation. After one week, a baseline cerebral SPECT was performed (1-3pm) and a baseline PSG was performed that night to evaluate the sleep pattern and the PLM index. Subsequently (after one week), each subject underwent a maximal exercise test (MET) in the morning (11am to 1pm) after which SPECT examination was performed in the afternoon (1-3 pm). A PSG was then performed that night to evaluate the effect of acute exercise on DAT density and sleep pattern (Figure 1).

02

Conditions studied

  • Periodic Limb Movements in Sleep

Keywords

  • PLM
  • dopamine
  • physical exercise
03

In context

Lead sponsor

Federal University of São Paulo is the lead sponsor of 427 studies on the registry; 22 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
45 Years to 65 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Inclusion criteria

  • With and without PLM,
  • no other health problems,
  • sedentary

Exclusion criteria

Exclusion Criteria:

  • Other clinical and neurological conditions,
  • continuous pharmacological treatment
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
16 participants (actual)

Study arms

  • Active comparator
    PLM group

    Individuals with increased periodic leg movement index (\>5)

    Behavioral: Aerobic Physical Exercise

  • Active comparator
    Non-PLM group

    Individuals with PLM index \<5

    Behavioral: Aerobic Physical Exercise

Interventions

  • BehavioralAerobic Physical Exercise

    All individuals were submitted to physical exercise reaching maximum effort

    Also known as: Acute Physical Exercise: Maximal Exercise Test

  • BehavioralAerobic Physical Exercise

    All individuals were submitted to physical exercise reaching maximum effort

    Also known as: Acute Physical Exercise: Maximal Exercise Test

06

What researchers measure

Primary outcomes

  1. Dopamine Transporter Density Measurement

    Dopamine Transporter Density Measurement assessed by SPECT using TRODAT-1

    Time frame: Baseline and after 5 hours of exercise effort measurements

Secondary outcomes

  1. Exercise Effort Maximum

    Exercise Effort VO2 maximum measurement

    Time frame: 1 week after baseline SPECT

07

Study locations

1 site
  • Centro de Estudos em Psicobiologia e Exercicio
    São Paulo, 04020-050, Brazil
08

References and documents

Publications

  • Earley CJ, Kuwabara H, Wong DF, Gamaldo C, Salas R, Brasic J, Ravert HT, Dannals RF, Allen RP. The dopamine transporter is decreased in the striatum of subjects with restless legs syndrome. Sleep. 2011 Mar 1;34(3):341-7. doi: 10.1093/sleep/34.3.341. PubMed 21358851 ↗
  • Mrowka M, Jobges M, Berding G, Schimke N, Shing M, Odin P. Computerized movement analysis and beta-CIT-SPECT in patients with restless legs syndrome. J Neural Transm (Vienna). 2005 May;112(5):693-701. doi: 10.1007/s00702-004-0217-9. Epub 2004 Oct 27. PubMed 15517434 ↗
  • Wetter TC, Eisensehr I, Trenkwalder C. Functional neuroimaging studies in restless legs syndrome. Sleep Med. 2004 Jul;5(4):401-6. doi: 10.1016/j.sleep.2004.01.009. PubMed 15223000 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 3, 2011, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01365364
Lead sponsor
Federal University of São Paulo
Collaborators
Fundação de Amparo à Pesquisa do Estado de São Paulo, Associação Fundo de Incentivo à Pesquisa
First posted
Jun 3, 2011
Start date
Mar 2009
Primary completion
Oct 2010
Completion
Dec 2010
Last update
Jun 3, 2011

Study contacts

Marco Tulio Mello, PhD
principal investigator · Federal University of São Paulo

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion